Citation: T. Doksum et al., Carrier screening for cystic fibrosis among Maryland obstetricians before and after the 1997 NIH consensus conference, GENET TEST, 5(2), 2001, pp. 111-116
Authors:
Tambor, ES
Bernhardt, BA
Geller, G
Helzlsouer, KJ
Doksum, T
Holtzman, NA
Citation: Es. Tambor et al., Should women at increased risk for breast and ovarian cancer be randomizedto prophylactic surgery? An ethical and empirical assessment, J WOMEN H G, 9(3), 2000, pp. 223-233
Authors:
Schoonmaker, MM
Bernhardt, BA
Holtzman, NA
Citation: Mm. Schoonmaker et al., Factors influencing health insurers' decisions to cover new genetic technologies, INT J TE A, 16(1), 2000, pp. 178-189
Citation: E. Mountcastle-shah et Na. Holtzman, Primary care physicians' perceptions of barriers to genetic testing and their willingness to participate in research, AM J MED G, 94(5), 2000, pp. 409-416
Citation: Mf. Myers et al., Genetic services for common complex disorders: Surveys of health maintenance organizations and academic genetic centers, GENET MED, 1(6), 1999, pp. 272-285
Authors:
Eisinger, F
Geller, G
Burke, W
Holtzman, NA
Citation: F. Eisinger et al., Cultural basis for differences between US and French clinical recommendations for women at increased risk of breast and ovarian cancer, LANCET, 353(9156), 1999, pp. 919-920
Citation: Na. Holtzman, Promoting safe and effective genetic tests in the United States: Work of the Task Force on Genetic Testing, CLIN CHEM, 45(5), 1999, pp. 732-738